These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32452334)

  • 1. Using the upper buttocks as a subcutaneous site for treprostinil infusion in children with pulmonary artery hypertension.
    Ono H; Yotani N; Kato H
    Cardiol Young; 2020 Jul; 30(7):1024-1025. PubMed ID: 32452334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, efficacy and Management of subcutaneous treprostinil infusions in the treatment of severe pediatric pulmonary hypertension.
    Levy M; Del Cerro MJ; Nadaud S; Vadlamudi K; Colgazier E; Fineman J; Bonnet D; Adatia I
    Int J Cardiol; 2018 Aug; 264():153-157. PubMed ID: 29650343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous treprostinil in pulmonary arterial hypertension: Practical considerations.
    Mathier MA; McDevitt S; Saggar R
    J Heart Lung Transplant; 2010 Nov; 29(11):1210-7. PubMed ID: 20855220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics.
    Siehr SL; Ivy DD; Miller-Reed K; Ogawa M; Rosenthal DN; Feinstein JA
    J Heart Lung Transplant; 2013 May; 32(5):546-52. PubMed ID: 23453572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treprostinil for pulmonary hypertension.
    Vachiéry JL; Naeije R
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treprostinil for pulmonary hypertension.
    Skoro-Sajer N; Lang I; Naeije R
    Vasc Health Risk Manag; 2008; 4(3):507-13. PubMed ID: 18827901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treprostinil for the treatment of pulmonary arterial hypertension.
    Torres F; Rubin LJ
    Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial.
    Grünig E; Benjamin N; Lange TJ; Krueger U; Klose H; Neurohr C; Wilkens H; Halank M; Seyfarth HJ; Held M; Traube A; Pernow M; Grover ER; Egenlauf B; Gerhardt F; Viethen T; Rosenkranz S
    Respiration; 2016; 92(6):362-370. PubMed ID: 27784026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension.
    Skoro-Sajer N; Gerges C; Balint OH; Kohalmi D; Kaldararova M; Simkova I; Jakowitsch J; Gabriel H; Baumgartner H; Gerges M; Sadushi-Kolici R; Celermajer DS; Lang IM
    Heart; 2018 Jul; 104(14):1195-1199. PubMed ID: 29436381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.
    Simonneau G; Barst RJ; Galie N; Naeije R; Rich S; Bourge RC; Keogh A; Oudiz R; Frost A; Blackburn SD; Crow JW; Rubin LJ;
    Am J Respir Crit Care Med; 2002 Mar; 165(6):800-4. PubMed ID: 11897647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of treprostinil in the management of pulmonary hypertension.
    Skoro-Sajer N; Lang I
    Am J Cardiovasc Drugs; 2008; 8(4):213-7. PubMed ID: 18690755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Treprostinil in Pediatric Pulmonary Hypertension: Case Reports and Review of the Literature.
    Gavotto A; Thomas F; Werner O; Moreau J; Amedro P
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):23-31. PubMed ID: 32168152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial.
    Sadushi-Kolici R; Jansa P; Kopec G; Torbicki A; Skoro-Sajer N; Campean IA; Halank M; Simkova I; Karlocai K; Steringer-Mascherbauer R; Samarzija M; Salobir B; Klepetko W; Lindner J; Lang IM
    Lancet Respir Med; 2019 Mar; 7(3):239-248. PubMed ID: 30477763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.
    Gomberg-Maitland M; Tapson VF; Benza RL; McLaughlin VV; Krichman A; Widlitz AC; Barst RJ
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1586-9. PubMed ID: 16151039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsaicin 8% patch for treprostinil subcutaneous infusion site pain in pulmonary hypertension patients.
    Libri V; Gibbs JS; Pinato DJ; Iddamalgoda T; Khengar RH; Gin-Sing W; Huson L; Anand P
    Br J Anaesth; 2014 Feb; 112(2):337-47. PubMed ID: 24062200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management of an acute subdural hematoma in a patient dependent on continuous treprostinil infusion therapy.
    Safain M; Shepard M; Rahal J; Kryzanski J; Hwang S; Roguski M; Riesenburger RI
    J Neurosurg; 2013 Apr; 118(4):753-6. PubMed ID: 23373804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.
    Enderby CY; Soukup M; Al Omari M; Zeiger T; Burger C
    J Clin Pharm Ther; 2014 Oct; 39(5):496-500. PubMed ID: 24806480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of subcutaneous treprostinil in pediatric pulmonary arterial hypertension-Bridge-to-transplant or long-term treatment?
    Ablonczy L; Tordas D; Kis E; Szatmári A
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29266571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitioning from i.v. epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension.
    Vachiéry JL; Hill N; Zwicke D; Barst R; Blackburn S; Naeije R
    Chest; 2002 May; 121(5):1561-5. PubMed ID: 12006444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8% Capsaicin Patch as Analgesia for Severe Treprostinil Infusion Site Pain.
    Light A; Heininger A; Wessman K; Frutiger K; White RJ
    Pain Med; 2017 Dec; 18(12):2515-2517. PubMed ID: 28541429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.